COMP <GO>
UNH vs MRK // ENTERPRISE SCALE & MARKET CAP
UnitedHealth Group Incorporated (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: UNH 7
— MRK 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
market-cap
$368.83B
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UNH VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UNH | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.57% | 74.80% | +13.77 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.47% | 20.70% | -9.23 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.4x | 15.3x | +1.15 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 6.48% | 3.42% | +3.06 | UNH | /fcf-yield <GO> |
| Operating Margin | 4.82% | 34.30% | -29.48 | MRK | /operating-margins <GO> |
| Net Profit Margin | 3.14% | 28.10% | -24.96 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 6.46% | 1.30% | +5.16 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.28% | 2.26% | +0.02 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.12 | 5.19 | -2.07 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.74% | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.2 | 51.7 | +7.50 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.33 | 0.92 | -0.59 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.7x | 18.4x | -0.66 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $368.83B | $361.02B | $7.81B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UNH REV | MRK REV | UNH GROSS % | MRK GROSS % | UNH FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $447.57B | $65.01B | 88.7% | 74.8% | $16.07B | $12.36B |
| FY 2024 | $400.28B | $64.17B | 88.3% | 76.3% | $20.70B | $18.10B |
| FY 2023 | $371.62B | $60.12B | 89.6% | — | $25.68B | $10.30B |
| FY 2022 | $324.16B | — | 89.6% | — | $23.40B | — |
| FY 2021 | $287.60B | — | 89.2% | — | $19.89B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UNH // BETA 0.33
MRK // BETA 0.92